Purpose: To report the chorioretinal coloboma, and its association with increased risk of retinal detachment (RD) and choroidal neovascularization (CNV). Methods: This retrospective case series included eyes with chorioretinal coloboma diagnosed between 1995 and 2014 with a focus on RD and CNV as related complications. Cases of CNV were managed with laser photocoagulation or intravitreal injection of bevacizumab. For eyes with CNV, therapeutic success was defined as resolution of the subretinal hemorrhage on fundus examination and resolution of the subretinal and intraretinal fluid on optical coherence tomography (OCT). For eyes with RD, anatomic success following surgical intervention was defined as attachment of the retina at the last follow-up visit. Results: Fifty-one eyes of 31 patients with chorioretinal coloboma were identified for review. Bilateral chorioretinal coloboma was present in 64.5% of subjects. RD developed in 15 eyes (29.4%). Among 15 eyes with RD, 4 eyes (27%) had retinal breaks identified within the coloboma, 5 eyes (33%) had retinal breaks outside the coloboma, 2 eyes (13%) showed retinal breaks both inside and outside the coloboma, and in 4 eyes (27%) the causative retinal break was not localized. The overall rate of anatomic success after RD repair was 85.7%. CNV developed in 7 eyes (13.7%) and was located along the margin of the coloboma in all cases. CNV was bilateral in 2 of the 5 affected individuals (40%). Conclusion: RD and CNV were present in a high percentage of eyes with chorioretinal coloboma in these series. The frequent finding of retinal breaks outside the coloboma bed suggests that vitreoretinal interface abnormalities may play a role in development of RD in these eyes.
INTRODUCTION
Chorioretinal coloboma is an uncommon congenital anomaly of the posterior segment occurring as a consequence of incomplete closure of the embryonic fissure during fetal development. Anatomical alterations in colobomatous eyes include atrophic retina, staphylomatous sclera, and absence of retinal pigment epithelium (RPE), Bruch's membrane, choriocapillaris, and choroid. RPE is thickened at the edge of the colobomas. [1] Patients with posterior segment colobomas are at risk for retinal detachment (RD) occurring as a consequence of retinal breaks located: (a) Outside the area of the coloboma, (b) inside the anomalous retinal tissue within the coloboma, or (c) both. [2] Colobomatous eyes are also at greater risk for choroidal neovascularization (CNV) caused by breaks in Bruch's membrane at the margin of the colobomas. [3] Herein, we retrospectively review a series of eyes with chorioretinal coloboma seen at our practice between 1995 and 2014, with a focus on the related complications of RD and CNV.
METHODS
This is an Institutional Review Board approved retrospective chart review of 31 patients (51 eyes) with a diagnosis of chorioretinal coloboma seen at Associated Retinal Consultants in Royal Oak, Michigan, USA between 1995 and 2014. All procedures were in line with the tenets of the Declaration of Helsinki. Patient demographics, clinical ophthalmic features, best corrected Snellen visual acuities (BCVA), and type of interventions were recorded. For eyes with RD, anatomic success following surgical intervention was defined as attachment of the retina at the last follow-up visit. For eyes with CNV, therapeutic success was defined as resolution of the subretinal hemorrhage on fundus examination and resolution of the subretinal and intraretinal fluid on optical coherence tomography (OCT).
RESULTS
Thirty-one patients with chorioretinal coloboma were identified. Since chorioretinal coloboma was present bilaterally in 20 (64.5%) patients, 51 eyes were included in this series. The male:female ratio was 14:17. Among patients with unilateral chorioretinal coloboma, 8 and 3 were affected in the right and left eyes, respectively. The chorioretinal colobomas were mostly located in the typical inferonasal location, though macular and optic nerve involvement was noted in 14/51 (27.4%) and 35/51 (68.7%) of eyes, respectively. An isolated peripapillary chorioretinal defect was present in 15/51 (29.4%) eyes. The mean and median duration of follow-up for the total pool of patients was 43 and 11 months, respectively.
An isolated retinal tear without RD was present in 2/51 (4%) of eyes in this series. Both tears were located in periphery, outside of the bed of the coloboma. One retinal tear was treated with laser, and for the treatment of the other cryotherapy was performed. Retina was attached in both eyes at the last follow-up evaluation. BCVA of the eye treated with laser was 20/400 both pre-and post-retinopexy. The eye treated with cryotherapy had final BCVA of 20/30, with no pretreatment BCVA recorded due to the patient's young age.
RD was present in 29.4% (15/51) of eyes at the initial referral visit. Mean age at presentation was 11 years (median 5 years; range, 6 weeks to 69 years). In eyes with RD, 27% (4/15) had retinal breaks identified within the coloboma, 33% (5/15) had retinal breaks outside the coloboma, 13% (2/15) had retinal breaks both inside and outside the coloboma, and in 27% (4/15) the causative retinal break was not localized [ Figure 1 ]. One eye presented with a concurrent choroidal detachment. Of 15 eyes with RD, 6 eyes (40%) subsequently developed proliferative vitreoretinopathy (PVR). The information pertaining to each eye with RD is summarized in Table 1 .
Of 15 eyes with RD, surgical repair was attempted in 14 eyes (93.3%). One eye was already phthisical at the time of presentation and did not undergo RD surgery. The total number of retinal reattachment procedures performed in this group was 28, with a mean of 2 interventions per eye. The initial surgical approach was generally pars plana vitrectomy with intraocular tamponade (93%, 13/14 eyes). Silicone oil was used as the intraocular tamponade in primary surgeries in 8 out of 13 eyes (61.5%). Finally, silicone oil was used in 77% (10/13) of eyes. The oil was ultimately removed in 30% (3/10) of eyes in which it was employed. One eye with silicone oil tamponade was complicated by migration of the oil into the anterior chamber with resultant glaucoma, zonular dehiscence, and band keratopathy (10%). Endolaser photocoagulation was performed around the margin of the coloboma in 50% (7/14) of eyes with retinal detachment. Anatomic success in this series was defined as the retina remaining attached at the last follow-up visit, irrespective of the number of surgeries. The overall rate of anatomic success achieved after RD repair was 86% (12/14 eyes). Out of the 13 eyes that underwent vitrectomy, 11 (85%) had reattached retinas at the last follow-up visit. Of the 10 eyes that received silicone oil tamponade, 8 (80%) maintained anatomic success up to the last follow-up visit. Mean and median follow-up length for all surgeries was 40.8 and 11 months, respectively.
Final BCVA data were available for 10 out of 14 eyes with RD, as age was a limiting factor for measuring the BCVA in some children. Sixty percent (6/10) of eyes had the final vision of hand motion (HM) or light perception (LP). One eye had the final BCVA of 20/80 after scleral buckling. Another eye presenting with a macula-sparing giant retinal tear away from the margin of the coloboma showed the final BCVA of 20/25 after scleral buckling and pars plana vitrectomy (PPV) with gas tamponade.
Fourteen percent (7/51) of eyes with chorioretinal coloboma developed CNV. Two of the five (40%) affected individuals had bilateral CNV. Mean age at presentation was 21.8 years (range, 10.5 months to 67 years). The CNV was located at the margin of the coloboma and within the macula in all eyes. Management of CNV in this series consisted of either laser photocoagulation (5/7, 71.4% of eyes), intravitreal bevacizumab (1/7, 14.3% of eyes), or observation (1/7, 14.3% of eyes). The eye treated pharmacologically received two monthly intravitreal bevacizumab (IVB) injections over a 10-week period. Only one eye was observed. All eyes showed resolution of subretinal hemorrhage and intraretinal and subretinal fluid at the last follow-up visit. Final BCVA was available for 3 out of 5 patients. The information pertaining to each case of CNV, along with comparison to other cases reported in the literature, is summarized in Table 2 . Mean and median follow up lengths for all CNV cases were 85.3 and 12 months, respectively.
The most common associated ocular feature was iris coloboma in 33% (16/49) of eyes. Other associated findings were CHARGE syndrome (coloboma, heart defects, atresia of the choanae, retardation of growth, genitourinary and ear abnormalities) in 7% (2/31) of patients, and MPPC syndrome (microcornea, posterior megalolenticonus, persistent fetal vasculature syndrome, coloboma) in 7% (2/31) of patients. Oculo-digital-dental syndrome (1/31 patients, 3%) and chromosome 22q11 gene deletion (1/31 patients, 3%) were noted as well.
DISCUSSION

Retinal Detachment in Eyes with Chorioretinal Coloboma
The incidence of RD in our series (31%) was within the range (2.4-42%) reported by prior studies. [1, [4] [5] [6] The high rate of RD in our series is likely a consequence of sequestration bias, as our center is a tertiary referral center for vitreoretinal diseases.
RD occurring in the setting of chorioretinal coloboma is particularly challenging to repair. [1] In our study, 43% of eyes with RDs required multiple procedures to achieve anatomic success. Of the eyes that underwent surgery, 86% showed successful reattachment of the retina at the last follow-up visit (mean follow-up period, 3.4 ± 3.0 years). Other reports in the literature cite success rates that range from 35-100% at last follow up visit. [5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Most notably, Gopal et al reported a 75% reattachment rate in the largest review of surgical management of RD in 85 colobomatous eyes. [9] Previous authors have postulated that the area of neurosensory retina within the coloboma (referred to as the intercalary membrane) is the most common area for breaks and detachments. [1, 9] In the current study, only 40% of RDs had tears within or at the margin of the coloboma, which falls on the lower end of previously reported rates of 38-100%. [7] [8] [9] [10] 12, 13, 19] Two colobomatous eyes in our study presented with a retinal tear without detachment, and both retinal breaks were located outside the colobomas. This may indicate the possibility of an abnormal vitreoretinal interface in colobomatous eyes that is not necessarily limited to the area of the coloboma and its margins. It also underscores the importance of conducting regular dilated funduscopic examinations focusing on the peripheral retina, in addition to the coloboma itself, for the identification of retinal tears.
Eyes with retinal breaks and detachment identified outside the margin of the coloboma may be managed with conventional scleral buckling techniques, though anatomical success rates are not encouraging, ranging from 35 to 57%. [8, 10] Breaks that occur within or along the margin of the coloboma present a more complex surgical challenge. [7, 13, 19] PPV, intraocular tamponade with either silicone oil or gas, and endophotocoagulation over the margin of the coloboma are common techniques for managing such detachments.
PPV offers the ability to identify and treat breaks in the intercalary membrane by endophotocoagulation, cryotherapy, or cyanoacrylate glue. [12, 17] In a review of surgical management of RD related to colobomas, Gopal and colleagues performed PPV and intraocular tamponade with either silicone oil (94%) or perfluoropropane (6%) in 85 eyes. They found that 81.2% of the retinas were still attached with a mean follow up of 13.4 months, and 69.4% of patients had final VA equal to or better than Data from other papers is presented for comparison. OD, right eye; OS, left eye; OU, both eyes; VA, visual acuity; ONH, optic nerve head; Mac, macula; CNVM, choroidal neovascular membrane; RD, retinal detachment; IVB, intravitreal bevacizumab; IVR, intravitreal ranibizumab; PDT, photodynamic therapy; F+F, fix and follow; CF, count fingers; HM, hand motion; NR, not reported 10/200. [9] We believe that no single technique could be applied universally to all cases of chorioretinal coloboma with RD. The surgical planning should be individualized with careful preoperative assessment of the RD.
Colobomatous RD is difficult to repair successfully, and visual prognosis is guarded, particularly in cases involving the macula. [8] In our series, the visual outcomes of RD repair were similarly unfavorable, as 6 out of 10 eyes (60%) had BCVA of HM or worse. The four eyes with final BCVA better than HM developed retinal breaks outside the coloboma, and the detachments did not involve the macula. Only four eyes had preoperative BCVA measurements, and the postoperative BCVA for each eye was either stable or slightly worse at the last follow-up. The amblyogenic effects of RD at an early stage of visual pathway development must be considered when discussing the limited final visual acuities in these patients, some of them being very young.
Given the guarded visual prognosis and frequent need for multiple surgeries, some may question the utility of operating on eyes with colobomatous RDs. However, a previous review of pediatric RDs found that 38% of eyes that underwent surgical repair had equal or better BCVA compared to their fellow eye at the final follow-up. [20] Furthermore, 89% of those patients had bilateral involvement of ocular abnormalities that could potentially limit vision. In our series, 65% of patients had bilateral chorioretinal colobomas, placing them at heightened risk of potential vision loss from RD and CNV in both eyes. Within the context of potential future vision loss in the currently uninvolved eye, the decision to operate on such complicated eyes with generally guarded prognoses remains appropriate.
The difficult management of colobomatous RDs and the heightened risk of RD in the setting of colobomas compel us to consider the need for prophylactic laser in all patients with chorioretinal colobomas. A recent review of chorioretinal colobomas in a pediatric population found a prevalence of 2.9% for RD in eyes that received prophylactic laser around the margin of the coloboma, as compared to 24.9% in eyes that did not receive laser. [21] In our series, only 40% (6/15) of RDs had tears within or at the margin of the coloboma, and the two colobomatous eyes in our study that presented with a retinal tear without detachment had retinal breaks located outside the coloboma. Given our findings, if one were to decide to perform prophylactic laser in eyes with chorioretinal colobomas, a greater benefit may be provided by lasering both around the margin of the coloboma and around the vitreous base (360°). If the margin of the coloboma extends significantly into the macula or abuts the fovea, the risk for significant visual impairment caused by laser may outweigh the benefit of prophylaxis for RD. This issue must also be carefully considered intraoperatively during repair of a colobomatous RD.
Choroidal Neovascularization in Eyes with
Chorioretinal Colobomas
The literature regarding coloboma associated CNV is currently limited to case reports and small case series. To the authors' knowledge, the current series of 7 eyes (5 patients) with chorioretinal colobomas and associated CNV represent the largest series reported to date.
The untreated natural history of coloboma associated CNV ranges from spontaneous resolution [22] to progressive worsening of visual acuity. [23] The primary modalities available for treatment of CNV are intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF), focal laser photocoagulation, and photodynamic therapy (PDT). Laser photocoagulation is the most frequently used method reported in the literature and has consistently resulted in regression of the CNV and improvement of visual acuity in these cases. [24] [25] [26] [27] [28] [29] It is generally avoided in cases of juxtafoveal or subfoveal CNV due to the high risk of iatrogenic vision loss.
In this series, CNV generally developed at a young age (median age of 15 years). The three children treated with laser had a mean age of 5.6 years (range, 10 months to 15 years). All five eyes treated with laser showed regression of CNV at the last follow-up examination (mean follow-up period, 11.3 ± 8.8 years). [26, 28, 29] All eyes treated for CNV in our study showed regression of subretinal hemorrhage and fluid. Several authors have reported the use of anti-VEGF injections and/or PDT in treating coloboma related CNV, summarized in Table 2 . [3, [30] [31] [32] [33] [34] [35] In the current series, intravitreal bevacizumab was used to successfully treat coloboma associated CNV in a 67-year-old patient with subfoveal hemorrhage and CNV. She had successful resolution of the hemorrhage and improvement in BCVA from CF to 20/200 at 2-month follow-up. The one patient who did not receive an intervention in our study had spontaneous regression of CNV after one month, and fluorescein angiography did not show evidence of leakage 12 months later.
Limitations of this study include its retrospective nature and limited patient population. Sequestration bias may skew the percentages toward a higher rate of CNV and RD, as patients with complex retinal pathology are more likely to be referred to a tertiary care center for management. Visual acuity data are limited in this study, as many patients were young children in whom visual acuity could not be reliably tested in the clinic setting.
In conclusion, chorioretinal colobomas are rare congenital anomalies that have potential to result in complications of RD and CNV. In cases of coloboma associated RD, often times multiple surgeries are necessary to achieve anatomic success. It is possible that an abnormality of the vitreoretinal interface may play a role in RD, given that a high percentage of retinal breaks were not found within the coloboma boundaries in this study. Coloboma associated CNV usually arises on the border of the colobomas. These cases can be successfully managed with laser or anti-VEGF therapy.
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